Luccas Manoel de Melo Suica

Luccas Manoel de Melo Suica

Auto-generated profile, based on publicly available information

Luccas Manoel de Melo Suica

Laboratory of Microorganism Biology, Oswaldo Cruz Foundation, Porto Velho, Rondônia, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2025 in Brazilian Journal of Oral Sciences
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
IRIzabelly Vitória Gotara Ramos
Izabelly Vitória Gotara Ramos
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
NMNajla Benevides Matos
Najla Benevides Matos
Patients admitted in the Intensive Care Units (ICUs) often experience various oral health issues during their hospitalization, which can lead to a shift in their oral flora from Gram-positive to pathogenic Gram-negative bacteria, including Pseudomonas aeruginosa. Aim: This study aimed to identify the colonization of P. aeruginosa in the oral cavity of ICU patients, as well as to assess its antimicrobial susceptibility profile, phenotypic resistance mechanisms, and biofilm-forming capacity. Methods: Oral cavity samples were collected from patients in ICUs across three public hospitals in Porto Velho, Rondônia, Brazil. Antimicrobial susceptibility testing was performed using the disk diffusion method, phenotypic research on resistance determinants was conducted using a disk method with and without the addition of enzymatic inhibitors, and biofilm formation was assessed by measuring absorbance in microplates. Results: A total of 114 oral cavity samples were obtained, with 28% showing colonization by P. aeruginosa. The antimicrobial susceptibility profile revealed that 93.7% of the isolates were susceptible to Polymyxin B. The highest rate of non-susceptibility was observed with levofloxacin (46.8%), followed by carbapenems: imipenem (43.7%) and meropenem (40.6%). Additionally, 37.5% of the isolates were classified as multidrug-resistant (MDR). In phenotypic research for carbapenemases, 35.7% of the isolates were positive for plasmid-mediated AmpC, and 14.3% were positive for Metallo-β-lactamases. Regarding biofilm production, 75% of the isolates were classified as moderate/strong biofilm producers. Conclusion: Therefore, oral cavity colonization by P. aeruginosa in ICU patients is evident, with notable multidrug resistance to antibiotics, highlighting the need for vigilant monitoring and effective oral hygiene practices for these patients.

25 April 2026 in International Microbiology
Verified
Journal Article
Open access
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
MBMayra Gyovana Leite Belém
Mayra Gyovana Leite Belém
ESErilene de Lima Sinos
Erilene de Lima Sinos
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
RRRenata Santos Rodrigues
Renata Santos Rodrigues
NMNajla Benevides Matos
Najla Benevides Matos
Group B Streptococcus (GBS) is a leading cause of preterm birth and neonatal infection. The COVID-19 pandemic substantially altered healthcare access, antibiotic use, and pathogen circulation. However, its influence on GBS remains poorly understood. This study evaluated temporal changes in GBS colonization, serotypes, and antimicrobial susceptibility among pregnant women in the Brazilian Amazon before, during, and after the COVID-19 pandemic. A total of 1,449 pregnant women at 35–37 weeks of gestation attending public health units in Porto Velho, Brazil, between February 2018 and November 2023 were included. Rectovaginal samples were cultured for GBS detection. Capsular serotyping and antimicrobial susceptibility testing were performed using standardized methods. Colonization prevalence, serotype distribution, and resistance profiles were compared across pre-pandemic, pandemic, and post-pandemic periods. Overall GBS colonization was detected in 20.7% (300/1,449) of participants, with variation across periods (22.6% before the pandemic, 21% during, and 19% after). Serotype Ia predominated (39%), followed by serotypes V (15.8%), II (14.1%), Ib (11.9%), III (10.2%), IV (5.1%), and VI (4%). Serotype distribution varied across periods without statistically significant differences. Non-susceptibility profiles differed significantly among serotypes. All isolates were susceptible to penicillin, ampicillin, cefazolin, and vancomycin. Increased non-susceptibility was observed for macrolides and levofloxacin, with multidrug-resistant (MDR) isolates rising from 5.7% to 15.9% post-pandemic. Together, these findings demonstrate temporal variation in GBS colonization, serotype distribution, and antimicrobial resistance across pre-, during-, and post-pandemic periods. While colonization, serotype distribution, and β-lactam susceptibility remained stable, significant increases in non-susceptibility to macrolides and levofloxacin, along with higher proportions of MDR profiles, were observed in later periods. These results highlight the importance of continued surveillance and provide relevant epidemiological insights to inform vaccine implementation and public health strategies in the post-pandemic era. The online version contains supplementary material available at 10.1007/s10123-026-00832-1.

21 March 2026 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
MCMárlon Grégori Flôres Custódio
Márlon Grégori Flôres Custódio
VFValcimar Batista Ferreira
Valcimar Batista Ferreira
NMNajla Benevides Matos
Najla Benevides Matos
Introduction: Pseudomonas aeruginosa is one of the leading agents of Healthcare-Associated Infections (HAIs), especially in Intensive Care Units (ICUs), where its intrinsic resistance, biofilm-forming ability, and acquisition of β-lactamase genes contribute to therapeutic failure and increased morbidity. Understanding the resistance mechanisms and clonal dynamics of this pathogen in clinical and hospital environments is essential for effective infection control. Results: Overall, 30.5% of the isolates were classified as MDR, with higher non-susceptibility rates to imipenem (41.2%) and meropenem (35.6%). Moderate/strong biofilm formation was observed in 77.3% of the isolates. A high prevalence of β-lactamase genes was detected, particularly blaCTX-M (38.8%), blaTEM (29.1%), blaGES (13.9%), and blaSHV (4.1%), whereas carbapenemase genes were infrequent ( blaVIM , blaKPC , blaIMP ; 1.8%). The blaCTX-M gene was significantly associated with MDR profiles and resistance to cefepime and ceftazidime. PFGE identified 16 clonal groups among 28 isolates, indicating transmission among patients, hospital surfaces, and different hospitals. MLST revealed 16 sequence types, including four novel STs, with predominance of ST3079. Methods: A total of 216 P. aeruginosa isolates obtained from hospitalized patients and hospital surfaces in three public hospitals in Porto Velho, Western Amazon, Brazil, were analyzed. Antimicrobial susceptibility was determined according to CLSI guidelines. Biofilm formation was evaluated in 96-well microplates. β-lactamase and carbapenemase genes were detected by PCR. Genetic relatedness was investigated by PFGE and MLST in multidrug-resistant (MDR) or carbapenem-resistant isolates. Conclusion: P. aeruginosa from ICU patients and hospital surfaces showed high multidrug resistance, strong biofilm production, and widespread β-lactamase genes, particularly blaCTX-M , a key determinant of the MDR phenotype. Clonal dissemination across hospitals and sources highlights the need for strengthened infection control, continuous molecular surveillance, and antimicrobial stewardship.